<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">OJGen</journal-id><journal-title-group><journal-title>Open Journal of Genetics</journal-title></journal-title-group><issn pub-type="epub">2162-4453</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/ojgen.2023.134009</article-id><article-id pub-id-type="publisher-id">OJGen-129628</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Biomedical&amp;Life Sciences</subject></subj-group></article-categories><title-group><article-title>
 
 
  Appropriate Means to Vulgarize the Human Cytogenetics
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Zhou</surname><given-names>Patricia Deh</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Abou</surname><given-names>Joël Landry Okon</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Gnaté</surname><given-names>François Montéomo</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Quidana</surname><given-names>Désirée Coulibaly</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Mimbra</surname><given-names>Olivia Annick Bouatinin</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Philippe</surname><given-names>Irenée Agossou</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Bi</surname><given-names>You Etienne Bazago Goulai</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Bi</surname><given-names>You Etienne Bazago Goulai</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Brahima</surname><given-names>Doukouré</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Gnangoran</surname><given-names>Victor Yao</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Mohenou</surname><given-names>Isidore Jean-Marie Diomandé</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib></contrib-group><aff id="aff3"><addr-line>Pathological Anatomy and Cytology Laboratory, UFR-Medical Sciences, Félix Houphou&amp;amp;#235;t-Boigny University, Abidjan, C&amp;amp;#244;te d’Ivoire</addr-line></aff><aff id="aff1"><addr-line>Histology-Embryology-Cytogenetics Laboratory, UFR-Medical Sciences, Félix Houphou&amp;amp;#235;t-Boigny University, Abidjan, C&amp;amp;#244;te d’Ivoire</addr-line></aff><aff id="aff2"><addr-line>Laboratory of Physiology, Pharmacology and Pharmacopoeia, UFR-Nature Sciences, Nangui-Abrogoua University, Abidjan, C&amp;amp;#244;te d’Ivoire</addr-line></aff><aff id="aff4"><addr-line>Laboratory of Clinical Cytology and Biology of Reproduction, UFR-Medical Sciences, Alassane Ouattara University, Bouaké, C&amp;amp;#244;te d’Ivoire</addr-line></aff><pub-date pub-type="epub"><day>06</day><month>12</month><year>2023</year></pub-date><volume>13</volume><issue>04</issue><fpage>125</fpage><lpage>133</lpage><history><date date-type="received"><day>4,</day>	<month>July</month>	<year>2023</year></date><date date-type="rev-recd"><day>3,</day>	<month>December</month>	<year>2023</year>	</date><date date-type="accepted"><day>6,</day>	<month>December</month>	<year>2023</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  <b>Purpose:</b>
   Insufficient epidemiological data on the prevalence of chromosomal abnormalities may hamper investments in research and interventions for better prevention and treatment of these major threats to the population in numerous countries. The aim of this literature review is to contribute to the popularization of cytogenetics. <b>Methodology:</b> This literature review is a text which contains, analyzes and organizes several referenced articles in French and English which have been selected from electronic databases. It provides a documentation of various activities and progress that have an interest in the field of cytogenetics. <b>Results:</b> In the context of cytogenetics, it is necessary to establish partnerships to strengthen infrastructures and produce quality results. The setting up of cytogenetic services and incentives for participatory research give space to the community in the production of knowledge and innovation, alongside researchers. It’s important to create biobanks, where samples of substances from the human body are collected for use in research into the causes and mechanisms of many diseases and their treatments. To carry out clinical trials aims at assessing the effectiveness of a therapeutic strategy, as is currently the case with the use of cytogenetic tests (karyotype, FISH, etc.) as tool of therapeutic decision and prognostic in cancer biology. The monitoring of the ethic of cytogenetic research projects allows protecting rights, security and welfare of subjects. To solve issues of data management and analysis such as the obstacle to the acquisition of tools and the insufficiency in the training of researchers. Furthermore, dissemination of research results will lead to better understanding of research results, greater public engagement in science and greater social respect for research. <b>Conclusion</b>: Cytogenetics can benefit from these actions such as the development of its research infrastructures and training programs for its workforce as well as the development of its clinical care. All this would have an impact on the population’s state of health.
 
</p></abstract><kwd-group><kwd>Human Cytogenetics</kwd><kwd> Vulgarization</kwd><kwd> Actions</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>Cytogenetics is a discipline that studies genetic material organized in the form of chromosomes. It provides the basic elements on which strategies for clinical or biological diagnosis of chromosomal anomalies, screening, prevention, monitoring and treatment are developed, including genetic counseling for families [<xref ref-type="bibr" rid="scirp.129628-ref1">1</xref>] [<xref ref-type="bibr" rid="scirp.129628-ref2">2</xref>] .</p><p>From its origins to the present day, cytogenetics has continued to progress in the analysis of its object of study, the human chromosome.</p><p>The first examination to analyze the chromosomes was the karyotype. New molecular cytogenetic technologies were developed which made it possible to identify chromosomal abnormalities down to a size of less than 5 megabases (MB) during the 1980s, then 1990s including fluorescence in situ hybridization (FISH) and the comparative genomic hybridization chip (array-CGH) [<xref ref-type="bibr" rid="scirp.129628-ref3">3</xref>] .</p><p>It is well known that chromosomal disorders are a significant cause of premature death or often lifelong disability [<xref ref-type="bibr" rid="scirp.129628-ref4">4</xref>] [<xref ref-type="bibr" rid="scirp.129628-ref5">5</xref>] [<xref ref-type="bibr" rid="scirp.129628-ref6">6</xref>] [<xref ref-type="bibr" rid="scirp.129628-ref7">7</xref>] .</p><p>Therefore, the results of literature review conducted in 2022 in Africa found that the proportion of chromosomal disorders among births with congenital anomalies was 8.94% (p &lt; 0.001) [<xref ref-type="bibr" rid="scirp.129628-ref4">4</xref>] . Nevertheless, observations mention an underestimation of epidemiological data in underdeveloped countries mainly linked to the insufficiency of local registry systems and records of real cases [<xref ref-type="bibr" rid="scirp.129628-ref4">4</xref>] [<xref ref-type="bibr" rid="scirp.129628-ref5">5</xref>] [<xref ref-type="bibr" rid="scirp.129628-ref8">8</xref>] [<xref ref-type="bibr" rid="scirp.129628-ref9">9</xref>] [<xref ref-type="bibr" rid="scirp.129628-ref10">10</xref>] . This may hinder investments in research and interventions for prevention and better treatment of chromosomal abnormalities in many countries [<xref ref-type="bibr" rid="scirp.129628-ref4">4</xref>] [<xref ref-type="bibr" rid="scirp.129628-ref7">7</xref>] .</p><p>In addition to this, health systems in developing countries are today faced with enormous challenges including the deficiency or absence of prenatal screening, cytogenetic diagnosis and associated services [<xref ref-type="bibr" rid="scirp.129628-ref4">4</xref>] [<xref ref-type="bibr" rid="scirp.129628-ref5">5</xref>] [<xref ref-type="bibr" rid="scirp.129628-ref7">7</xref>] [<xref ref-type="bibr" rid="scirp.129628-ref8">8</xref>] . There are also other factors such as the insufficiency and obsolescence of equipment, lack of qualified human resources and fundings [<xref ref-type="bibr" rid="scirp.129628-ref4">4</xref>] [<xref ref-type="bibr" rid="scirp.129628-ref8">8</xref>] [<xref ref-type="bibr" rid="scirp.129628-ref11">11</xref>] . All these problems therefore prevent the patient to benefit from adequate care and adapted genetic counseling [<xref ref-type="bibr" rid="scirp.129628-ref5">5</xref>] [<xref ref-type="bibr" rid="scirp.129628-ref7">7</xref>] .</p><p>In view of the aforementioned difficulties, a question arises. How to improve the quality and quantity of human cytogenetics research?</p><p>The objective of this literature review is to contribute to the popularization of cytogenetics from a set of actions that are topical.</p></sec><sec id="s2"><title>2. Methodology</title><p>The systematic literature review aims to provide an overview of various current activities and developments that are of interest in the field of human cytogenetics based on relevant literature. Starting from the objective, the investigations focused on several concepts:</p><p>- Roles of partnership in research,</p><p>- The place of cytogenetic services,</p><p>- Contributions of participatory research,</p><p>- Roles of biobanks,</p><p>- Interests of clinical trials,</p><p>- Advantages of monitoring the ethics of research projects,</p><p>- Adequate management and analysis of research data,</p><p>- And the importance of disseminating research results.</p><p>Thus, a documentary search of articles in French and English dating from 2021 to 2023 was undertaken to obtain an idea of all previous notions using electronic databases. The references of 37 selected publications were taken into account.</p></sec><sec id="s3"><title>3. Results</title><p>The results of this work have been grouped in a table (<xref ref-type="table" rid="table1">Table 1</xref>) which displays the contributions of a certain number of current actions whose implementation of which helps to fill existing deficits or allows continued progression in the field of cytogenetics.</p></sec><sec id="s4"><title>4. Discussion</title><p>This review identifies a number of current initiatives that would be of benefit to cytogenetics. These are analysed in this work to highlight the relevance of their implementation.</p><p>In low- and middle-income countries such as Africa, chromosomal abnormalities are likely to be underestimated due to the lack of accurate data on the causes of death [<xref ref-type="bibr" rid="scirp.129628-ref4">4</xref>] . Chromosomal disorders form a major category of genetic diseases [<xref ref-type="bibr" rid="scirp.129628-ref12">12</xref>] . They have a huge impact on overall health and well-being, causing multiple problems including mental retardation and/or physical disabilities [<xref ref-type="bibr" rid="scirp.129628-ref4">4</xref>] .</p><p>However, most African economies allocate only scarce resources to the health research and private investment in this area is also modest. Thus, cooperation with developed countries will make help to strengthen research capacities by obtaining subsidies and producing quality results [<xref ref-type="bibr" rid="scirp.129628-ref13">13</xref>] [<xref ref-type="bibr" rid="scirp.129628-ref14">14</xref>] .</p><p>The establishment of efficient and reliable cytogenetic services or laboratories constitutes the places for diagnosis of chromosomal abnormalities [<xref ref-type="bibr" rid="scirp.129628-ref5">5</xref>] . These</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Set of processes suitable for advancing cytogenetics [<xref ref-type="bibr" rid="scirp.129628-ref5">5</xref>] [<xref ref-type="bibr" rid="scirp.129628-ref12">12</xref>] - [<xref ref-type="bibr" rid="scirp.129628-ref37">37</xref>] </title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Actions to be taken</th><th align="center" valign="middle" >Benefits</th></tr></thead><tr><td align="center" valign="middle" >Development and maintenance of the partnerships</td><td align="center" valign="middle" >○ Strengthens infrastructure ○ Access to equipment specialized or to new sources of funding ○ Produces quality results</td></tr><tr><td align="center" valign="middle" >Setting up cytogenetic services</td><td align="center" valign="middle" >○ Cytogenetic diagnosis: identification of chromosomal abnormalities of number and structural ○ Use of different techniques: karyotype, FISH and array-CGH</td></tr><tr><td align="center" valign="middle" >To promote participatory research</td><td align="center" valign="middle" >○ Gives the place to the community in the production of knowledge and Innovation alongside researchers ○ Members of communities can contribute to the design, the implementation and analysis of quantitative or qualitative research data ○ Allows people to be heard on the issue of their own development</td></tr><tr><td align="center" valign="middle" >Creation of biobanks</td><td align="center" valign="middle" >○ Collection of samples of substances from the human body (tissues, blood, DNA, cell pellets, etc.) associated with personal data on their donors ○ Role in researching the causes and mechanisms of disease as well as their treatments ○ Intended to serve scientific research ○ Increases sample availability</td></tr><tr><td align="center" valign="middle" >Conduct of clinical trials</td><td align="center" valign="middle" >○ Aims to assess non-toxicity, tolerance and efficacy of a diagnostic method or a therapeutic strategy: cytogenetic tests for therapeutic decision and prognosis</td></tr><tr><td align="center" valign="middle" >To monitor the ethics of cytogenetic research projects</td><td align="center" valign="middle" >○ Allows you to approve the conduct of research projects on subjects human beings and to periodically monitor its progress in order to ensure the protection of the rights of the subjects, as well as their safety and their well-being.</td></tr><tr><td align="center" valign="middle" >To solve problems of data management and analysis (example, obstacle to the acquisition of tools)</td><td align="center" valign="middle" >○ Provides the ability to describe, reduce, classify and clarify the data showing similarities or differences between variables or groups of variables</td></tr><tr><td align="center" valign="middle" >Dissemination of research results (Books, Articles, Poster communications, Websites, etc.)</td><td align="center" valign="middle" >○ Intended to attract the attention of governments or stakeholders on research results, giving a social, political or economic impact ○ Increase the visibility and understanding of research</td></tr></tbody></table></table-wrap><p>structures offer tests, including karyotype, fluorescence in situ hybridization (FISH) and comparative genomic hybridization chip (array-CGH) in pre and postnatal. Chromosomal analysis techniques are performed from a variety of samples including amniotic fluid, chorionic villi, peripheral venous blood, bone marrow and lymph nodes [<xref ref-type="bibr" rid="scirp.129628-ref5">5</xref>] [<xref ref-type="bibr" rid="scirp.129628-ref15">15</xref>] [<xref ref-type="bibr" rid="scirp.129628-ref16">16</xref>] .</p><p>In addition to previous actions, the development of participatory research is an approach that aims to conduct research by involving the community (associations, families, people with disabilities) and researchers from the study design to the analyze of data. Thus the level of community participation is attracting increasing interest in health science research [<xref ref-type="bibr" rid="scirp.129628-ref17">17</xref>] [<xref ref-type="bibr" rid="scirp.129628-ref18">18</xref>] . For example, associations actively are engaged in biological and clinical research. This commitment takes various forms such as raising awareness of diseases, disseminating knowledge of pathologies and supporting doctoral students. Added to this co-financing of infrastructures and equipments, as well as participation in clinical trials [<xref ref-type="bibr" rid="scirp.129628-ref17">17</xref>] [<xref ref-type="bibr" rid="scirp.129628-ref19">19</xref>] .</p><p>It is important to create biobanks that are places of systematic collections of human bodily samples (organs, tissues, blood and cells) as well as DNA as a carrier of genetic material [<xref ref-type="bibr" rid="scirp.129628-ref20">20</xref>] .</p><p>The major objective of biobanks is to preserve these resources in optimal conditions in order to maintain their integrity and to make them available to the scientific community in general and in particular to facilitate the search for medicines and innovative diagnostic tests [<xref ref-type="bibr" rid="scirp.129628-ref21">21</xref>] [<xref ref-type="bibr" rid="scirp.129628-ref22">22</xref>] [<xref ref-type="bibr" rid="scirp.129628-ref23">23</xref>] .</p><p>In the context of research, a clinical trial is a carefully designed prospective medical study that attempts to accurately answer a set of questions about the effects of a special treatment.</p><p>The WHO (World Health Organization) classification of haemopathies has included since 2001 into cytogenetic data [<xref ref-type="bibr" rid="scirp.129628-ref24">24</xref>] . Thus, in oncology, cytogenetic tests such as karyotype and FISH play a key role in diagnosis, prognosis, choice and monitoring of treatment [<xref ref-type="bibr" rid="scirp.129628-ref24">24</xref>] [<xref ref-type="bibr" rid="scirp.129628-ref25">25</xref>] .</p><p>Research projects carried out on genetic diseases have made it possible to acquire new knowledge such as genetic testing, genetic counseling, prenatal diagnosis, assisted procreation technologies, embryo manipulation and the constitution of biobanks [<xref ref-type="bibr" rid="scirp.129628-ref23">23</xref>] [<xref ref-type="bibr" rid="scirp.129628-ref26">26</xref>] . They raise multiple ethical issues including the participation of minors in research, incidental findings, the protection of privacy and the interpretation of genetic findings in a personal or family referral. In addition, it is necessary to take into account the right to physical integrity but also the right to decide on the use of personal data [<xref ref-type="bibr" rid="scirp.129628-ref23">23</xref>] [<xref ref-type="bibr" rid="scirp.129628-ref26">26</xref>] [<xref ref-type="bibr" rid="scirp.129628-ref27">27</xref>] . In view of the above observations, it is necessary to emphasize that research protocols in the field of cytogenetics should be examined and approved by the local operational ethics committee.</p><p>Moreover, data represents information collected during the conduct of a research project. Their analysis and interpretation is a phase which essentially includes operations of classification, comparison, on each of the information collected in order to find its meaning and to draw conclusions [<xref ref-type="bibr" rid="scirp.129628-ref28">28</xref>] [<xref ref-type="bibr" rid="scirp.129628-ref29">29</xref>] [<xref ref-type="bibr" rid="scirp.129628-ref30">30</xref>] . In the area of research, there is a need for additional support in the management and analysis of large datasets as there seems to be a lack of knowledge about tools and resources for data management. Barriers to acquiring currently available tools are most often related to the financial burdens of small labs and unmet expectations for institutional support [<xref ref-type="bibr" rid="scirp.129628-ref28">28</xref>] [<xref ref-type="bibr" rid="scirp.129628-ref29">29</xref>] [<xref ref-type="bibr" rid="scirp.129628-ref30">30</xref>] .</p><p>Institutions should facilitate the training of researchers in management strategies for conducting preserved data themselves, using for example secure networks and data encryption by user authentication through the password [<xref ref-type="bibr" rid="scirp.129628-ref28">28</xref>] [<xref ref-type="bibr" rid="scirp.129628-ref29">29</xref>] [<xref ref-type="bibr" rid="scirp.129628-ref30">30</xref>] .</p><p>Dissemination of research is an integral part of the research process. It involves communicating research results to the target community, to decision-makers and others who may benefit from knowledge produced. Research released findings leads to better understanding of findings, increased public engagement in science and greater social respect for research [<xref ref-type="bibr" rid="scirp.129628-ref31">31</xref>] [<xref ref-type="bibr" rid="scirp.129628-ref32">32</xref>] .</p><p>There are several ways in which researchers communicate the results of their research. These include writing a book, a journal article or a communication aimed at the general public, and then organizing round tables. Other elements to consider include the creation of websites specific to the research project and the creation of mural or poster for public spaces. A researcher could also associate with others pursuing similar research objectives [<xref ref-type="bibr" rid="scirp.129628-ref32">32</xref>] .</p><p>The interest of this study lies in the application of these measures which contribute to the benefits of cytogenetics in <xref ref-type="table" rid="table1">Table 1</xref>.</p><p>At the clinical level, the etiological diagnosis of chromosomal abnormalities makes thus it possible to specify the prognosis and set up appropriate medical follow-up then a systematic screening for complications. Appropriate genetic counseling on the risk of recurrence of the disease can also be established [<xref ref-type="bibr" rid="scirp.129628-ref33">33</xref>] .</p><p>In the fields of teaching and research, the acquisition of laboratory materials and equipment allows to offer significant learning experiences to learners in universities and to develop research [<xref ref-type="bibr" rid="scirp.129628-ref34">34</xref>] .</p><p>At national level, the above measures would enable the adoption of a prevention policy to limit the risks of spreading chromosomal abnormalities [<xref ref-type="bibr" rid="scirp.129628-ref35">35</xref>] .</p><p>It is also desirable, as in some countries, to implement a legal and ethical framework, followed by legislation, for the practice of genetic counseling, pre or postnatal diagnosis. Should be added to previous list clinical trials, the creation of biobanks and prescriptions in the field of cytogenetics, with a view to protecting the rights of subjects, their safety and well-being [<xref ref-type="bibr" rid="scirp.129628-ref23">23</xref>] [<xref ref-type="bibr" rid="scirp.129628-ref26">26</xref>] [<xref ref-type="bibr" rid="scirp.129628-ref36">36</xref>] [<xref ref-type="bibr" rid="scirp.129628-ref37">37</xref>] .</p></sec><sec id="s5"><title>5. Conclusion</title><p>Cytogenetics is a clinico-biological discipline that is complemented and perpetuated by new research. Its funding could remain a priority in the government’s economic recovery plan that is the development of its research infrastructures and training programs and for its workforce, as well as the development of its clinical care. This contributes to improving the life expectancy, quality of life and individual well-being.</p></sec><sec id="s6"><title>Author’s Contributions</title><p>ZPD collected the data. ZPD, AJLO, GFM, QDC, MOAB, PIA, BYEBG, BD, GVY, MIJMD have contributed to the data analysis.</p></sec><sec id="s7"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest regarding the publication of this paper.</p></sec><sec id="s8"><title>Cite this paper</title><p>Deh, Z.P., Okon, A.J.L., Mont&#233;omo, G.F., Coulibaly, Q.D., Bouatinin, M.O.A., Agossou, P.I., Goulai, B.Y.E.B., Doukour&#233;, B., Victor Yao, G. and Diomand&#233;, M.I.J.-M. (2023) Appropriate Means to Vulgarize the Human Cytogenetics. Open Journal of Genetics, 13, 125-133. https://doi.org/10.4236/ojgen.2023.134009</p></sec></body><back><ref-list><title>References</title><ref id="scirp.129628-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Heng, E., Thanedar, S. and Heng, H.H. (2023) Challenges and Opportunities for Clinical Cytogenetics in the 21st Century. Genes, 14, Article No. 493. https://doi.org/10.3390/genes14020493</mixed-citation></ref><ref id="scirp.129628-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Liehr, T. (2021) Molecular Cytogenetics in the Era of Chromosomics and Cytogenomic Approaches. Frontiers in Genetics, 12, Article ID: 720507. https://doi.org/10.3389/fgene.2021.720507</mixed-citation></ref><ref id="scirp.129628-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Bedei, I., Wolter, A., Weber, A., Signore, F. and Axt-Fliedner, R. (2021) Chances and Challenges of New Genetic Screening Technologies (NIPT) in Prenatal Medicine from a Clinical Perspective: A Narrative Review. Genes (Basel), 12, Article No. 501. https://doi.org/10.3390/genes12040501</mixed-citation></ref><ref id="scirp.129628-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Gebremeskel, A.T. and Seyoum, G.G. (2022) Proportion of Chromosomal Disorders and Their Patterns among Births with Congenital Anomalies in Africa: A Systematic Review and Meta-Analyses. The Scientific World Journal, 2022, Article ID: 6477596. https://doi.org/10.1155/2022/6477596</mixed-citation></ref><ref id="scirp.129628-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Deh, Z.P., Goulai, B.Y.E.B., Montéomo, G.F., Coulibaly, Q.D., Dieth, M.J.A., Okon, A.J.L., et al. (2022) Contribution to the Struggle against Chromosomal Abnormalities from Literature Review. International Journal of Genetics and Genomics, 10, 48-52.</mixed-citation></ref><ref id="scirp.129628-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Azonbakin, S., Ouedraogo, A., Ouedraogo, A., Sewadouno, D., Agbanlinsou, A., Goussanou, Y., et al. (2021) Chromosome Polymorphism and Human Pathology: About 27 Cases of Chromosome 9 Inversion in the Beninese Population. Open Journal of Genetics, 11, 23-31. https://doi.org/10.4236/ojgen.2021.113003</mixed-citation></ref><ref id="scirp.129628-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Hosen, M.J., Anwar, S., Taslem, M.J., et al. (2021) Genetic Counseling in the Context of Bangladesh: Current Scenario, Challenges, and a Framework for Genetic Service Implementation. Orphanet Journal of Rare Diseases, 16, Article No. 168. https://doi.org/10.1186/s13023-021-01804-6</mixed-citation></ref><ref id="scirp.129628-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">El-Attar, L.M., Bahashwan, A.A., Bakhsh, A.D. and Moshrif, Y.M. (2021) The Prevalence and Patterns of Chromosome Abnormalities in Newborns with Major Congenital Anomalies: A Retrospective Study from Saudi Arabia. Intractable &amp; Rare Diseases Research, 10, 81-87. https://doi.org/10.5582/irdr.2021.01016</mixed-citation></ref><ref id="scirp.129628-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Huber, A.N., Pascoe, S., Fox, M.P., Murphy, J., Phokojoe, M., Gorgens, M., et al. (2023) Leveraging Routine Data in Impact Evaluation: Understanding Data Systems in Primary Healthcare Prior to a Matched Cluster-Randomised Evaluation of Adherence Guidelines in South Africa. South African Medical Journal, 112, 819-827. https://doi.org/10.7196/SAMJ.2022.v112i10.14909</mixed-citation></ref><ref id="scirp.129628-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Malherbe, H.L., Aldous, C., Christianson, A.L., Darlison, M.W. and Modell, B.M. (2021) Epidemiological Data for Selected Congenital Disorders in South Africa. Journal of Community Genetics, 12, 357-376. https://doi.org/10.1007/s12687-021-00513-8</mixed-citation></ref><ref id="scirp.129628-ref11"><label>11</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Koffi</surname><given-names> L.B. </given-names></name>,<etal>et al</etal>. (<year>2022</year>)<article-title>La santé publique en C&amp;#244;te d’Ivoire: Un secteur clé de développement en difficulté (1980-1994)</article-title><source> International Journal of Humanities and Social Science Invention</source><volume> 11</volume>,<fpage> 38</fpage>-<lpage>44</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.129628-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Bechar, M.E.A., Guyader, J.M., Bouz, M.E., Douet-Guilbert, N., Falou, A.A. and Troadec, M.B. (2023) Highly Performing Automatic Detection of Structural Chromosomal Abnormalities Using Siamese Architecture. Journal of Molecular Biology, 435, Article ID: 168045. https://doi.org/10.1016/j.jmb.2023.168045</mixed-citation></ref><ref id="scirp.129628-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Zanuso, C., Roudier, P., Chetboun, D., Le Coguic, R., Osman, Y., Dia, D., et al. (2021) Agence fran&amp;#231;aise de développement. L’économie africaine 2021. Edition: La Découverte, Collection, Repères, 128 p.</mixed-citation></ref><ref id="scirp.129628-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Wenham, C., Wouters, O., Jones, C., et al. (2021) Measuring Health Science Research and Development in Africa: Mapping the Available Data. Health Research Policy and Systems, 19, Article No. 142. https://doi.org/10.1186/s12961-021-00778-y</mixed-citation></ref><ref id="scirp.129628-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Carlotto, B.S., Deconte, D., Diniz, B.L., Silva, P.R.D., Zen, P.R.G. and Silva, A.A.D. (2023) Fluorescence in Situ Hybridization (FISH) as an Irreplaceable Diagnostic Tool for Williams-Beuren Syndrome in Developing Countries: A Literature Review. Revista Paulista de Pediatria, 42, e2022125. https://doi.org/10.1590/1984-0462/2023/41/2022125</mixed-citation></ref><ref id="scirp.129628-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Karim, S., Hussein, I.R., Schulten, H.J., Alsaedi, S., Mirza, Z., Al-Qahtani, M., et al. (2023) Identification of Extremely Rare Pathogenic CNVs by Array CGH in Saudi Children with Developmental Delay, Congenital Malformations, and Intellectual Disability. Children, 10, Article No. 662. https://doi.org/10.3390/children10040662</mixed-citation></ref><ref id="scirp.129628-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Cornish, F., Breton, N., Moreno-Tabarez, U., et al. (2023) Participatory Action Research. Nature Reviews Methods Primers, 3, Article No. 34. https://doi.org/10.1038/s43586-023-00214-1</mixed-citation></ref><ref id="scirp.129628-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">Sipari, S., V&amp;#228;nsk&amp;#228;, N., Lehtonen, K., Helenius, S., Harra, T., Kinnunen, A., et al. (2023) Participatory Research Partnership in Rehabilitation Co-Development of a Model for Collaboration Process. Disabilities, 3, 410-425. https://doi.org/10.3390/disabilities3030027</mixed-citation></ref><ref id="scirp.129628-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">Duea, S.R., Zimmerman, E.B., Vaughn, L.M., Dias, S. and Harris, J. (2022) A Guide to Selecting Participatory Research Methods Based on Project and Partnership Goals. Journal of Participatory Research Methods, 3, 1-28. https://doi.org/10.35844/001c.32605</mixed-citation></ref><ref id="scirp.129628-ref20"><label>20</label><mixed-citation publication-type="other" xlink:type="simple">Annaratone, L., De Palma, G., Bonizzi, G., et al. (2021) Basic Principles of Biobanking: From Biological Samples to Precision Medicine for Patients. Virchows Archiv, 479, 233-246. https://doi.org/10.1007/s00428-021-03151-0</mixed-citation></ref><ref id="scirp.129628-ref21"><label>21</label><mixed-citation publication-type="other" xlink:type="simple">Lewis, J. and Holm, S. (2022) Organoid Biobanking, Autonomy and the Limits of Consent. Bioethics, 36, 742-746. https://doi.org/10.1111/bioe.13047</mixed-citation></ref><ref id="scirp.129628-ref22"><label>22</label><mixed-citation publication-type="other" xlink:type="simple">Tanaka, K., Kato, I., Dobashi, Y., Imai, J.I., Mikami, T., Kubota, H., et al. (2022) The First Japanese Biobank of Patient-Derived Pediatric Acute Lymphoblastic Leukemia Xenograft Models. Cancer Science, 113, 14-25. https://doi.org/10.1111/cas.15506</mixed-citation></ref><ref id="scirp.129628-ref23"><label>23</label><mixed-citation publication-type="other" xlink:type="simple">Casati, S., Ellul, B., Mayrhofer, M.T., Lavitrano, M., Caboux, E. and Kozlakidis, Z. (2022) Paediatric Biobanking for Health: The Ethical, Legal and Societal Landscape. Frontiers in Public Health, 10, Article ID: 917615. https://doi.org/10.3389/fpubh.2022.917615</mixed-citation></ref><ref id="scirp.129628-ref24"><label>24</label><mixed-citation publication-type="other" xlink:type="simple">Arber, D.A., Attilio Orazi, A., Hasserjian, R.P., Borowitz, M.J., Calvo, K.R., Kvasnicka, H.M., et al. (2022) International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: Integrating Morphologic, Clinical, and Genomic Data. Blood, 140, 1200-1228. https://doi.org/10.1182/blood.2022015850</mixed-citation></ref><ref id="scirp.129628-ref25"><label>25</label><mixed-citation publication-type="other" xlink:type="simple">Ababneh, O., Za’nouneh, F.J.A., Schinke, C., Thanendrarajan, S., Zangari, M., Shaughnessy, J.D., et al. (2022) The Use and Reporting of Cytogenetics in Phase III Multiple Myeloma Clinical Trials. Blood, 140, 532-533. https://doi.org/10.1182/blood-2022-158282</mixed-citation></ref><ref id="scirp.129628-ref26"><label>26</label><mixed-citation publication-type="other" xlink:type="simple">Al-Fayyad, I., Al-Tannir, M., Abu-Shaheen, A., et al. (2021) To Disclose, or Not to Disclose? Perspectives of Clinical Genomics Professionals toward Returning Incidental Findings from Genomic Research. BMC Medical Ethics, 22, Article No. 101. https://doi.org/10.1186/s12910-021-00670-y</mixed-citation></ref><ref id="scirp.129628-ref27"><label>27</label><mixed-citation publication-type="other" xlink:type="simple">Mezinska, S., Gallagher, L., Verbrugge, M., et al. (2021) Ethical Issues in Genomics Research on Neurodevelopmental Disorders: A Critical Interpretive Review. Human Genomics, 15, Article No. 16. https://doi.org/10.1186/s40246-021-00317-4</mixed-citation></ref><ref id="scirp.129628-ref28"><label>28</label><mixed-citation publication-type="other" xlink:type="simple">Falahat, M., Cheah, P.K., Jayabalan, J., Lee, C.M.J. and Kai, S.B. (2023) Big Data Analytics Capability Ecosystem Model for SMEs. Sustainability, 15, Article No. 360. https://doi.org/10.3390/su15010360</mixed-citation></ref><ref id="scirp.129628-ref29"><label>29</label><mixed-citation publication-type="other" xlink:type="simple">Birkbeck, G., Nagleand, T. and Sammon, D.J. (2022) Challenges in Research Data Management Practices: A Literature Analysis. Journal of Decision Systems, 31, 53-67. https://doi.org/10.1080/12460125.2022.2074653</mixed-citation></ref><ref id="scirp.129628-ref30"><label>30</label><mixed-citation publication-type="other" xlink:type="simple">Thuermer, G., Guardia, E.G., Reeves, N., Corcho, O. and Simperl, E. (2023) Data Management Documentation in Citizen Science Projects: Bringing Formalisation and Transparency Together. Citizen Science: Theory and Practice, 8, Article No. 25. https://doi.org/10.5334/cstp.538</mixed-citation></ref><ref id="scirp.129628-ref31"><label>31</label><mixed-citation publication-type="other" xlink:type="simple">Perra, M. and Brinkman, T. (2021) Seeing Science: Using Graphics to Communicate Research. Ecosphere, 12, e03786. https://doi.org/10.1002/ecs2.3786</mixed-citation></ref><ref id="scirp.129628-ref32"><label>32</label><mixed-citation publication-type="other" xlink:type="simple">Borowiec, B.G. (2023) Ten Simple Rules for Scientists Engaging in Science Communication. PLOS Computational Biology, 19, e1011251. https://doi.org/10.1371/journal.pcbi.1011251</mixed-citation></ref><ref id="scirp.129628-ref33"><label>33</label><mixed-citation publication-type="other" xlink:type="simple">Turbitt, E., Jacobs, C. and McEwen, A. (2023) Special Issue: Genetic Counseling and Genetic Testing in Precision Medicine. Journal of Personalized Medicine, 13, Article No. 1192. https://doi.org/10.3390/jpm13081192</mixed-citation></ref><ref id="scirp.129628-ref34"><label>34</label><mixed-citation publication-type="other" xlink:type="simple">Goldstein, B. and Avasthi, P. (2021) A Guide to Setting up and Managing a Lab at a Research-Intensive Institution. BMC Proceedings, 15, Article No. 8. https://doi.org/10.1186/s12919-021-00214-7</mixed-citation></ref><ref id="scirp.129628-ref35"><label>35</label><mixed-citation publication-type="other" xlink:type="simple">Mijumbi-Deve, R., Parkhurst, J., Jones, C., Juma, P.A., Sobngwi-Tambekou, J.L. and Wenham, C. (2021) Beyond the Metrics of Health Research Performance in African Countries. BMJ Global Health, 6, e006019. https://doi.org/10.1136/bmjgh-2021-006019</mixed-citation></ref><ref id="scirp.129628-ref36"><label>36</label><mixed-citation publication-type="other" xlink:type="simple">Kruse, J., Mueller, R., Aghdassi, A.A., Lerch, M.M. and Salloch, S. (2022) Genetic Testing for Rare Diseases: A Systematic Review of Ethical Aspects. Frontiers in Genetics, 12, Article ID: 701988. https://doi.org/10.3389/fgene.2021.701988</mixed-citation></ref><ref id="scirp.129628-ref37"><label>37</label><mixed-citation publication-type="other" xlink:type="simple">Grill, K. and Rosén, A. (2021) Healthcare Professionals’ Responsibility for Informing Relatives at Risk of Hereditary Disease. Journal of Medical Ethics, 47, e12. https://doi.org/10.1136/medethics-2020-106236</mixed-citation></ref></ref-list></back></article>